NALOXONE

NALOXONE was reported 24312 times

NALOXONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTEMORTEM BLOOD DRUG LEVEL ABNORMAL 11 0.8462
1 GLABELLAR REFLEX ABNORMAL 7 0.3684
2 RHESUS INCOMPATIBILITY 43 0.3554
3 BLOOD ETHANOL 11 0.2619
4 POSTMORTEM BLOOD DRUG LEVEL 11 0.1864
5 CHANTER SYNDROME 9 0.0900
6 POSTMORTEM BLOOD DRUG LEVEL ABNORMAL 12 0.0816
7 THYMUS DISORDER 10 0.0524
8 BRIEF PSYCHOTIC DISORDER WITH MARKED STRESSORS 8 0.0497
9 IMPAIRED INSULIN SECRETION 5 0.0424
10 CEREBRAL CONGESTION 7 0.0417
11 PARAPSORIASIS 11 0.0409
12 PELVIC HAEMATOMA 14 0.0317
13 RESTRICTIVE CARDIOMYOPATHY 9 0.0297
14 ACUTE ON CHRONIC LIVER FAILURE 6 0.0278
15 NON-CARDIOGENIC PULMONARY OEDEMA 29 0.0274
16 OPIATES POSITIVE 13 0.0271
17 BRACHYDACTYLY 5 0.0254
18 NEURODEGENERATIVE DISORDER 15 0.0243
19 SALIVARY GLAND DISORDER 11 0.0235
20 PERINEAL PAIN 15 0.0210
21 FUNGAL FOOT INFECTION 9 0.0205
22 SUBSTANCE DEPENDENCE 13 0.0193
23 ATRIOVENTRICULAR DISSOCIATION 4 0.0187
24 URETHRAL STENOSIS 12 0.0176
25 COUNTERFEIT DRUG ADMINISTERED 6 0.0174
26 METASTATIC GASTRIC CANCER 6 0.0174
27 TACHYPHYLAXIS 6 0.0172
28 NAIL RIDGING 9 0.0171
29 DRUG EFFECT PROLONGED 9 0.0163
30 BRADYPNOEA 43 0.0159
31 INTESTINAL INFARCTION 14 0.0154
32 PULMONARY ARTERY STENOSIS 6 0.0153
33 AMPHETAMINES POSITIVE 11 0.0147
34 TONGUE MOVEMENT DISTURBANCE 12 0.0140
35 DRUG-GENETIC INTERACTION 5 0.0140
36 BENIGN NEOPLASM OF THYROID GLAND 10 0.0136
37 RESPIRATORY DEPRESSION 166 0.0135
38 BREECH PRESENTATION 17 0.0135
39 MIOSIS 98 0.0122
40 MULTIPLE DRUG THERAPY 9 0.0119
41 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 7 0.0116
42 MYOCARDIAL INJURY 13 0.0116
43 ACNE PUSTULAR 9 0.0110
44 ACCIDENTAL POISONING 15 0.0109
45 RESPIRATORY ACIDOSIS 43 0.0109
46 RESPIRATORY ALKALOSIS 17 0.0104
47 RENAL INFARCT 15 0.0104
48 COCCYDYNIA 15 0.0102
49 HYPERCREATININAEMIA 5 0.0099
50 ENTEROCOCCAL SEPSIS 8 0.0099
51 DELAYED RECOVERY FROM ANAESTHESIA 9 0.0095
52 HYPERCAPNIA 28 0.0093
53 RESPIRATORY RATE DECREASED 29 0.0092
54 ANION GAP INCREASED 12 0.0090
55 HEART TRANSPLANT 8 0.0088
56 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 23 0.0088
57 CYTOKINE STORM 6 0.0088
58 RETROPERITONEAL HAEMATOMA 19 0.0086
59 PNEUMOMEDIASTINUM 15 0.0083
60 GENERALISED ANXIETY DISORDER 12 0.0082
61 BRUGADA SYNDROME 8 0.0077
62 CYSTITIS INTERSTITIAL 12 0.0075
63 VERTEBRAL FORAMINAL STENOSIS 6 0.0073
64 FOETAL DISTRESS SYNDROME 15 0.0071
65 TOXIC LEUKOENCEPHALOPATHY 5 0.0069
66 HYPORESPONSIVE TO STIMULI 8 0.0068
67 UNRESPONSIVE TO STIMULI 173 0.0067
68 SYSTOLIC DYSFUNCTION 7 0.0066
69 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 5 0.0064
70 APLASTIC ANAEMIA 32 0.0061
71 DILATED CARDIOMYOPATHY 6 0.0059
72 JAUNDICE NEONATAL 11 0.0058
73 PUPIL FIXED 10 0.0058
74 STRESS CARDIOMYOPATHY 33 0.0057
75 DRUG DIVERSION 34 0.0055
76 VASOPLEGIA SYNDROME 9 0.0055
77 ARTERIOSCLEROSIS CORONARY ARTERY 36 0.0054
78 APNOEA 42 0.0054
79 AXILLARY PAIN 8 0.0054
80 RETROPERITONEAL HAEMORRHAGE 13 0.0053
81 MATERNAL EXPOSURE DURING DELIVERY 5 0.0050
82 NEPHROGENIC ANAEMIA 23 0.0050
83 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 13 0.0049
84 SYSTEMIC INFECTION 8 0.0048
85 PULMONARY SEPSIS 7 0.0048
86 TOXICITY TO VARIOUS AGENTS 801 0.0047
87 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 5 0.0047
88 BLOOD CULTURE POSITIVE 14 0.0047
89 ALCOHOL WITHDRAWAL SYNDROME 4 0.0046
90 COMPARTMENT SYNDROME 12 0.0046
91 APLASIA 9 0.0046
92 PILOERECTION 5 0.0046
93 BRAIN DEATH 14 0.0045
94 SUBSTANCE USE 7 0.0045
95 RHEUMATOID FACTOR INCREASED 5 0.0045
96 TORSADE DE POINTES 35 0.0045
97 ESSENTIAL HYPERTENSION 8 0.0044
98 INSULIN RESISTANCE 9 0.0043
99 OSTEOCHONDROSIS 5 0.0043
100 PULSELESS ELECTRICAL ACTIVITY 18 0.0043
101 NECROTISING FASCIITIS 15 0.0043
102 HEPATIC NECROSIS 16 0.0042
103 ACUTE LUNG INJURY 5 0.0042
104 ODYNOPHAGIA 25 0.0042
105 HYPERTONIC BLADDER 12 0.0042
106 PAINFUL RESPIRATION 10 0.0041
107 SEDATION COMPLICATION 10 0.0039
108 PUPILLARY REFLEX IMPAIRED 7 0.0038
109 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
110 PULMONARY ALVEOLAR HAEMORRHAGE 21 0.0037
111 METABOLIC ALKALOSIS 6 0.0037
112 SINUS TACHYCARDIA 53 0.0037
113 SACROILIITIS 7 0.0037
114 DEAFNESS NEUROSENSORY 12 0.0036
115 DEPRESSED LEVEL OF CONSCIOUSNESS 143 0.0036
116 EXPOSURE VIA BREAST MILK 14 0.0035
117 TRANSFUSION 36 0.0034
118 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
119 VENTRICULAR HYPOKINESIA 11 0.0034
120 POISONING 43 0.0034
121 NORMOCYTIC ANAEMIA 5 0.0034
122 THYROID MASS 13 0.0034
123 DRUG WITHDRAWAL SYNDROME NEONATAL 50 0.0034
124 YAWNING 9 0.0034
125 CARDIAC DEATH 4 0.0033
126 CLONUS 9 0.0033
127 ACCIDENTAL DRUG INTAKE BY CHILD 5 0.0033
128 OSTEOSCLEROSIS 5 0.0032
129 INCREASED BRONCHIAL SECRETION 8 0.0031
130 ADENOCARCINOMA PANCREAS 4 0.0031
131 DISTRIBUTIVE SHOCK 7 0.0031
132 BILIARY OBSTRUCTION 4 0.0031
133 STREPTOCOCCAL INFECTION 17 0.0031
134 ELECTROCARDIOGRAM QT PROLONGED 109 0.0030
135 LARGE INTESTINE PERFORATION 21 0.0030
136 ACUTE RESPIRATORY FAILURE 58 0.0030
137 PREMATURE DELIVERY 48 0.0030
138 ALCOHOL ABUSE 8 0.0030
139 PULMONARY OEDEMA 133 0.0030
140 HYPOXIA 104 0.0030
141 SEIZURE LIKE PHENOMENA 5 0.0029
142 OSTEOLYSIS 6 0.0029
143 CACHEXIA 15 0.0029
144 NEUTROPENIC COLITIS 6 0.0029
145 PRODUCT COUNTERFEIT 5 0.0029
146 HYPOPNOEA 10 0.0029
147 CULTURE URINE POSITIVE 4 0.0028
148 LEFT VENTRICULAR HYPERTROPHY 12 0.0028
149 HYPERPARATHYROIDISM SECONDARY 7 0.0028
150 BRAIN OEDEMA 35 0.0028
151 KLEBSIELLA INFECTION 14 0.0028
152 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 14 0.0027
153 HYPERACUSIS 10 0.0027
154 IRON DEFICIENCY 12 0.0027
155 COMA 127 0.0027
156 METABOLIC ENCEPHALOPATHY 8 0.0027
157 DRUG ABUSE 221 0.0027
158 BLOOD ALBUMIN DECREASED 21 0.0026
159 LEARNING DISABILITY 14 0.0026
160 MENTAL STATUS CHANGES 72 0.0026
161 HYPERREFLEXIA 9 0.0026
162 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 20 0.0026
163 TOOTH INJURY 11 0.0025
164 DRUG SCREEN POSITIVE 20 0.0025
165 BENIGN PROSTATIC HYPERPLASIA 13 0.0025
166 ANTICHOLINERGIC SYNDROME 4 0.0025
167 ORTHOPNOEA 8 0.0025
168 ORAL CANDIDIASIS 33 0.0025
169 TACHYPNOEA 34 0.0025
170 DIABETES INSIPIDUS 6 0.0025
171 CAESAREAN SECTION 29 0.0025
172 SEROTONIN SYNDROME 47 0.0024
173 CARDIOGENIC SHOCK 35 0.0024
174 VENOOCCLUSIVE LIVER DISEASE 12 0.0024
175 LIVEDO RETICULARIS 5 0.0024
176 DRUG USE DISORDER 20 0.0024
177 TORTICOLLIS 5 0.0024
178 BRAIN HERNIATION 7 0.0023
179 BLOOD PH DECREASED 4 0.0023
180 AORTIC ARTERIOSCLEROSIS 6 0.0023
181 NORMOCHROMIC NORMOCYTIC ANAEMIA 7 0.0023
182 BLOOD CHLORIDE DECREASED 6 0.0023
183 ACUTE PULMONARY OEDEMA 13 0.0023
184 ATRIOVENTRICULAR BLOCK FIRST DEGREE 10 0.0023
185 LUNG OPACITY 6 0.0023
186 APPETITE DISORDER 15 0.0023
187 HYPERLACTACIDAEMIA 6 0.0022
188 ADENOCARCINOMA 5 0.0022
189 OVERDOSE 477 0.0022
190 PULMONARY CONGESTION 29 0.0022
191 DELUSION 34 0.0022
192 BREAKTHROUGH PAIN 5 0.0022
193 NECK MASS 6 0.0021
194 CARDIAC ARREST 173 0.0021
195 BRAIN INJURY 21 0.0021
196 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
197 OLIGURIA 13 0.0021
198 SUBSTANCE ABUSE 17 0.0021
199 BLOOD LACTIC ACID INCREASED 11 0.0021
200 PYELONEPHRITIS 18 0.0021
201 DELIRIUM 72 0.0021
202 COMA SCALE ABNORMAL 6 0.0021
203 RESPIRATORY FAILURE 150 0.0021
204 HYPOVOLAEMIA 12 0.0020
205 PREMATURE BABY 61 0.0020
206 CREPITATIONS 6 0.0020
207 ANAL INCONTINENCE 18 0.0020
208 ENCEPHALOPATHY 49 0.0020
209 REBOUND ACID HYPERSECRETION 6 0.0020
210 PSEUDOMONAS INFECTION 17 0.0020
211 CLOSTRIDIUM DIFFICILE COLITIS 21 0.0020
212 METABOLIC ACIDOSIS 63 0.0020
213 SINUS BRADYCARDIA 19 0.0020
214 ESCHERICHIA INFECTION 16 0.0019
215 BONE LESION 7 0.0019
216 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
217 RENAL TUBULAR NECROSIS 19 0.0019
218 TALIPES 6 0.0019
219 AKINESIA 4 0.0019
220 ACCIDENTAL EXPOSURE 8 0.0019
221 CONGESTIVE CARDIOMYOPATHY 8 0.0019
222 BLOOD CREATININE DECREASED 6 0.0019
223 PERSONALITY DISORDER 5 0.0019
224 METASTASES TO BONE 31 0.0019
225 NYSTAGMUS 10 0.0019
226 LEUKOENCEPHALOPATHY 7 0.0019
227 CARDIAC FAILURE CHRONIC 8 0.0019
228 BRADYKINESIA 11 0.0019
229 ATELECTASIS 18 0.0019
230 EXOSTOSIS 17 0.0019
231 SNORING 7 0.0018
232 HYPOVENTILATION 6 0.0018
233 TENDON DISORDER 12 0.0018
234 DRUG TOXICITY 25 0.0018
235 ACIDOSIS 14 0.0018
236 LEUKOCYTOSIS 33 0.0018
237 STAPHYLOCOCCAL SEPSIS 9 0.0018
238 RHABDOMYOLYSIS 76 0.0018
239 END STAGE RENAL DISEASE 33 0.0018
240 PARANOIA 31 0.0018
241 DRUG WITHDRAWAL SYNDROME 157 0.0018
242 POTENTIATING DRUG INTERACTION 6 0.0018
243 ENDOTRACHEAL INTUBATION 5 0.0018
244 BRADYCARDIA 94 0.0018
245 LUMBAR VERTEBRAL FRACTURE 8 0.0017
246 THROMBOPHLEBITIS 6 0.0017
247 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
248 HAEMODYNAMIC INSTABILITY 13 0.0017
249 VENTRICULAR TACHYCARDIA 28 0.0017
250 BUNDLE BRANCH BLOCK LEFT 7 0.0016
251 DUODENITIS 5 0.0016
252 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
253 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
254 HALLUCINATION, VISUAL 34 0.0016
255 INTENTIONAL OVERDOSE 103 0.0016
256 SEDATION 42 0.0016
257 HYPERAMMONAEMIA 8 0.0016
258 ONYCHOMYCOSIS 7 0.0016
259 SPINAL OSTEOARTHRITIS 14 0.0016
260 CORONARY ARTERY STENOSIS 8 0.0016
261 LUNG INFILTRATION 14 0.0016
262 EXTRASYSTOLES 11 0.0016
263 HEPATITIS B REACTIVATION 5 0.0016
264 HYPERTHERMIA 12 0.0016
265 FEBRILE NEUTROPENIA 104 0.0016
266 CANCER PAIN 4 0.0016
267 MYDRIASIS 20 0.0016
268 CARDIOMEGALY 19 0.0015
269 ABDOMINAL HERNIA 7 0.0015
270 ACUTE KIDNEY INJURY 234 0.0015
271 HEPATOTOXICITY 34 0.0015
272 UROSEPSIS 14 0.0015
273 ANURIA 13 0.0015
274 CEREBRAL ATROPHY 6 0.0015
275 ALCOHOL POISONING 4 0.0015
276 DISSEMINATED INTRAVASCULAR COAGULATION 21 0.0015
277 HYPOTHERMIA 15 0.0015
278 ACCIDENTAL OVERDOSE 54 0.0015
279 METASTASES TO CENTRAL NERVOUS SYSTEM 19 0.0015
280 ACUTE RESPIRATORY DISTRESS SYNDROME 26 0.0015
281 ELECTROLYTE IMBALANCE 17 0.0015
282 HYPERCALCAEMIA 18 0.0015
283 PUSTULAR PSORIASIS 5 0.0015
284 RESPIRATORY DISTRESS 40 0.0014
285 ENTEROCOCCAL INFECTION 7 0.0014
286 TROPONIN INCREASED 11 0.0014
287 OBESITY 23 0.0014
288 VENTRICULAR FIBRILLATION 16 0.0014
289 UPPER GASTROINTESTINAL HAEMORRHAGE 24 0.0014
290 PANCREATIC DISORDER 7 0.0014
291 HOSPICE CARE 14 0.0014
292 STATUS EPILEPTICUS 16 0.0014
293 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
294 AORTIC VALVE INCOMPETENCE 6 0.0014
295 FIBRIN D DIMER INCREASED 5 0.0014
296 MYOCARDIAL ISCHAEMIA 16 0.0014
297 INTERVERTEBRAL DISC DEGENERATION 13 0.0014
298 THERAPY NON-RESPONDER 63 0.0014
299 ACUTE HEPATIC FAILURE 19 0.0014
300 FLANK PAIN 13 0.0014
301 HYPOKALAEMIA 64 0.0014
302 BLOOD URIC ACID INCREASED 8 0.0014
303 TOXIC ENCEPHALOPATHY 7 0.0014
304 PATHOLOGICAL FRACTURE 7 0.0014
305 AGITATION 101 0.0014
306 SPONDYLITIS 5 0.0014
307 AUTONOMIC NERVOUS SYSTEM IMBALANCE 4 0.0014
308 VENTRICULAR ARRHYTHMIA 5 0.0014
309 PNEUMONIA ASPIRATION 34 0.0014
310 CEREBRAL ISCHAEMIA 7 0.0014
311 ARTHROPOD BITE 10 0.0013
312 ATRIOVENTRICULAR BLOCK SECOND DEGREE 4 0.0013
313 SLEEP APNOEA SYNDROME 25 0.0013
314 DRUG LEVEL ABOVE THERAPEUTIC 6 0.0013
315 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 8 0.0013
316 HYPERKALAEMIA 45 0.0013
317 CARDIOPULMONARY FAILURE 5 0.0013
318 TUBULOINTERSTITIAL NEPHRITIS 24 0.0013
319 PULMONARY HAEMORRHAGE 10 0.0013
320 FAECALOMA 7 0.0013
321 RESPIRATORY ARREST 35 0.0013
322 HYPERKERATOSIS 7 0.0013
323 IDIOPATHIC PULMONARY FIBROSIS 5 0.0013
324 CHRONIC KIDNEY DISEASE 96 0.0013
325 PULSE ABSENT 6 0.0013
326 HAEMATOCRIT DECREASED 25 0.0013
327 RENAL CYST 10 0.0013
328 DEMENTIA 35 0.0013
329 CIRCULATORY COLLAPSE 21 0.0012
330 SPINAL FUSION SURGERY 5 0.0012
331 DECUBITUS ULCER 10 0.0012
332 PERIPHERAL ISCHAEMIA 5 0.0012
333 DEVELOPMENTAL DELAY 11 0.0012
334 FOETAL EXPOSURE DURING PREGNANCY 99 0.0012
335 TRANSAMINASES INCREASED 27 0.0012
336 RED CELL DISTRIBUTION WIDTH INCREASED 5 0.0012
337 NEUROTOXICITY 21 0.0012
338 DRUG TOLERANCE 6 0.0012
339 INADEQUATE ANALGESIA 10 0.0012
340 LIPASE INCREASED 9 0.0012
341 MYOCLONUS 14 0.0012
342 MUSCLE TWITCHING 27 0.0012
343 FEMORAL NECK FRACTURE 6 0.0012
344 ARTERIOSCLEROSIS 11 0.0012
345 LETHARGY 67 0.0012
346 RESPIRATION ABNORMAL 8 0.0012
347 HEPATIC LESION 5 0.0012
348 PELVIC PAIN 21 0.0012
349 MATERNAL EXPOSURE DURING PREGNANCY 103 0.0012
350 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
351 HAEMATEMESIS 29 0.0011
352 GASTRITIS 30 0.0011
353 HAND FRACTURE 8 0.0011
354 HYPOTENSION 226 0.0011
355 ILEUS 14 0.0011
356 HEPATOMEGALY 11 0.0011
357 BREAST CANCER METASTATIC 12 0.0011
358 SHOCK HAEMORRHAGIC 9 0.0011
359 SUICIDE ATTEMPT 67 0.0011
360 SCREAMING 7 0.0011
361 DRUG INTERACTION 174 0.0011
362 ASPIRATION 12 0.0011
363 RESTLESSNESS 40 0.0011
364 RENAL FAILURE 145 0.0011
365 INTESTINAL ISCHAEMIA 6 0.0011
366 BUNDLE BRANCH BLOCK RIGHT 5 0.0011
367 DRUG LEVEL INCREASED 18 0.0011
368 VAGINAL DISCHARGE 11 0.0011
369 SHOCK 25 0.0011
370 AMYLASE INCREASED 4 0.0011
371 ARTHRITIS INFECTIVE 5 0.0011
372 DRUG DEPENDENCE 172 0.0011
373 BLOOD CALCIUM DECREASED 12 0.0011
374 MICTURITION URGENCY 12 0.0010
375 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 18 0.0010
376 GENERAL PHYSICAL HEALTH DETERIORATION 121 0.0010
377 HYPOVOLAEMIC SHOCK 5 0.0010
378 FAECAL INCONTINENCE 5 0.0010
379 STILLBIRTH 5 0.0010
380 EJECTION FRACTION DECREASED 16 0.0010
381 HYPOALBUMINAEMIA 8 0.0010
382 COGNITIVE DISORDER 48 0.0010
383 SPLENOMEGALY 12 0.0010
384 TACHYCARDIA 91 0.0010
385 EYE MOVEMENT DISORDER 7 0.0010
386 ELECTROCARDIOGRAM ABNORMAL 8 0.0010
387 CYANOSIS 16 0.0010
388 JOINT EFFUSION 7 0.0010
389 PERITONITIS 21 0.0010
390 SEPTIC SHOCK 44 0.0010
391 BACTERAEMIA 12 0.0010
392 HYPOGLYCAEMIA 49 0.0010
393 PULMONARY HYPERTENSION 21 0.0010
394 ABDOMINAL TENDERNESS 5 0.0010
395 HYPERTRANSAMINASAEMIA 7 0.0010
396 SOMNOLENCE 202 0.0010
397 HYPERTENSIVE CRISIS 11 0.0010
398 DYSLIPIDAEMIA 5 0.0010
399 OCULAR DISCOMFORT 11 0.0010
400 MUSCLE SPASTICITY 12 0.0010
401 SMALL INTESTINAL OBSTRUCTION 12 0.0010
402 MITRAL VALVE INCOMPETENCE 11 0.0010
403 SEPSIS 108 0.0010
404 EMBOLISM 8 0.0010
405 FAILURE TO THRIVE 5 0.0010
406 IMPAIRED GASTRIC EMPTYING 13 0.0010
407 CYTOKINE RELEASE SYNDROME 19 0.0009
408 HYPERGLYCAEMIA 34 0.0009
409 COORDINATION ABNORMAL 13 0.0009
410 WITHDRAWAL SYNDROME 39 0.0009
411 VITAMIN D DEFICIENCY 9 0.0009
412 HYPERLIPIDAEMIA 11 0.0009
413 MUSCLE RIGIDITY 11 0.0009
414 BRADYPHRENIA 6 0.0009
415 PRODUCT PRESCRIBING ISSUE 20 0.0009
416 HYDROCEPHALUS 5 0.0009
417 ANKYLOSING SPONDYLITIS 12 0.0009
418 TOOTH FRACTURE 10 0.0009
419 ATRIOVENTRICULAR BLOCK 7 0.0009
420 ABDOMINAL ABSCESS 4 0.0009
421 HEAD DISCOMFORT 16 0.0009
422 CARDIAC FAILURE ACUTE 6 0.0009
423 ON AND OFF PHENOMENON 5 0.0009
424 DYSURIA 33 0.0009
425 JOINT RANGE OF MOTION DECREASED 12 0.0009
426 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
427 OXYGEN SATURATION DECREASED 50 0.0009
428 GENERALISED OEDEMA 11 0.0009
429 SICKLE CELL ANAEMIA WITH CRISIS 14 0.0009
430 HYPONATRAEMIA 50 0.0009
431 REBOUND EFFECT 10 0.0009
432 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 6 0.0009
433 ALTERED STATE OF CONSCIOUSNESS 19 0.0009
434 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 48 0.0009
435 SENSORY DISTURBANCE 14 0.0009
436 HYPERBILIRUBINAEMIA 9 0.0009
437 GRAND MAL CONVULSION 8 0.0009
438 DIVERTICULITIS 24 0.0009
439 RIGHT VENTRICULAR FAILURE 6 0.0009
440 POLYURIA 7 0.0009
441 DUODENAL ULCER 6 0.0008
442 ASCITES 25 0.0008
443 DECREASED INTEREST 5 0.0008
444 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24 0.0008
445 SPINAL DISORDER 8 0.0008
446 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 5 0.0008
447 POISONING DELIBERATE 8 0.0008
448 RENAL INJURY 25 0.0008
449 PANCYTOPENIA 47 0.0008
450 CHOLECYSTITIS 10 0.0008
451 AGGRESSION 42 0.0008
452 ATRIAL SEPTAL DEFECT 7 0.0008
453 GANGRENE 5 0.0008
454 SKIN LACERATION 9 0.0008
455 PNEUMOTHORAX 13 0.0008
456 DENTAL CARIES 9 0.0008
457 CARDIO-RESPIRATORY ARREST 34 0.0008
458 SCOLIOSIS 5 0.0008
459 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
460 LACTIC ACIDOSIS 26 0.0008
461 PRE-EXISTING CONDITION IMPROVED 5 0.0008
462 URINE OUTPUT DECREASED 7 0.0008
463 TUMOUR LYSIS SYNDROME 7 0.0008
464 LYMPHOCYTE COUNT DECREASED 14 0.0008
465 ECONOMIC PROBLEM 12 0.0008
466 FEELING COLD 22 0.0008
467 RESPIRATORY RATE INCREASED 7 0.0008
468 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
469 CARDIOTOXICITY 7 0.0008
470 DISORIENTATION 31 0.0008
471 DEVICE OCCLUSION 11 0.0008
472 EUPHORIC MOOD 8 0.0008
473 MYOSITIS 7 0.0008
474 PROCTALGIA 5 0.0008
475 OSTEOMYELITIS 14 0.0008
476 INTENTIONAL PRODUCT MISUSE 67 0.0008
477 DYSKINESIA 31 0.0008
478 HAEMOGLOBIN DECREASED 78 0.0008
479 ACCIDENT 9 0.0008
480 HAEMOPTYSIS 21 0.0008
481 COMPRESSION FRACTURE 4 0.0007
482 HYPOPHAGIA 19 0.0007
483 URINARY INCONTINENCE 22 0.0007
484 ANAL ABSCESS 4 0.0007
485 WRONG PRODUCT ADMINISTERED 5 0.0007
486 BEHAVIOUR DISORDER 4 0.0007
487 RIB FRACTURE 15 0.0007
488 OSTEOPENIA 11 0.0007
489 LYMPHOEDEMA 5 0.0007
490 ENCEPHALITIS 5 0.0007
491 CYSTIC FIBROSIS 4 0.0007
492 EOSINOPHIL COUNT INCREASED 6 0.0007
493 URINARY RETENTION 24 0.0007
494 DEVICE RELATED INFECTION 11 0.0007
495 HALLUCINATION 53 0.0007
496 ROTATOR CUFF SYNDROME 9 0.0007
497 BLOOD MAGNESIUM DECREASED 6 0.0007
498 CELLULITIS 35 0.0007
499 CARDIAC MURMUR 6 0.0007
500 LIVER INJURY 17 0.0007
501 RESPIRATORY SYNCYTIAL VIRUS INFECTION 6 0.0007
502 ATRIAL FIBRILLATION 67 0.0007
503 FLUID OVERLOAD 10 0.0007
504 MAJOR DEPRESSION 5 0.0007
505 GROIN PAIN 6 0.0007
506 MOUTH HAEMORRHAGE 5 0.0007
507 LOSS OF CONSCIOUSNESS 87 0.0007
508 COVID-19 PNEUMONIA 8 0.0007
509 GAMMA-GLUTAMYLTRANSFERASE INCREASED 15 0.0007
510 CARDIOMYOPATHY 10 0.0007
511 PLEURAL EFFUSION 41 0.0007
512 MANIA 11 0.0007
513 POLYNEUROPATHY 8 0.0007
514 PULMONARY EMBOLISM 63 0.0007
515 JOINT DISLOCATION 7 0.0007
516 CONSTIPATION 144 0.0007
517 STOMATITIS 40 0.0007
518 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
519 DISABILITY 13 0.0007
520 THROMBOCYTOPENIA 73 0.0007
521 MATERNAL DRUGS AFFECTING FOETUS 5 0.0007
522 ANAEMIA 124 0.0006
523 IRON DEFICIENCY ANAEMIA 6 0.0006
524 MUCOSAL INFLAMMATION 17 0.0006
525 HYPOMAGNESAEMIA 9 0.0006
526 HEPATIC ENCEPHALOPATHY 6 0.0006
527 NERVOUS SYSTEM DISORDER 20 0.0006
528 SEIZURE 74 0.0006
529 PHOTOPHOBIA 12 0.0006
530 PARALYSIS 9 0.0006
531 ORAL PAIN 14 0.0006
532 ASPARTATE AMINOTRANSFERASE INCREASED 33 0.0006
533 RHINITIS 5 0.0006
534 SKIN ULCER 16 0.0006
535 DYSSTASIA 18 0.0006
536 AUTOIMMUNE DISORDER 6 0.0006
537 IRRITABILITY 37 0.0006
538 ABNORMAL FAECES 5 0.0006
539 ANHEDONIA 16 0.0006
540 HYPERAESTHESIA 5 0.0006
541 LIGAMENT SPRAIN 6 0.0006
542 SPINAL COMPRESSION FRACTURE 5 0.0006
543 HYPOTONIA 6 0.0006
544 COAGULOPATHY 10 0.0006
545 SPINAL PAIN 7 0.0006
546 HAEMODIALYSIS 5 0.0006
547 BLOOD CREATINE PHOSPHOKINASE INCREASED 17 0.0006
548 EYELID PTOSIS 6 0.0006
549 ATAXIA 7 0.0006
550 OSTEOARTHRITIS 25 0.0006
551 PLASMA CELL MYELOMA 23 0.0006
552 TOOTH ABSCESS 6 0.0006
553 CHILLS 69 0.0006
554 INSURANCE ISSUE 9 0.0006
555 PNEUMONITIS 16 0.0006
556 MYOPATHY 5 0.0006
557 TOOTH LOSS 12 0.0006
558 MULTI-ORGAN FAILURE 10 0.0006
559 HYSTERECTOMY 5 0.0006
560 BURSITIS 7 0.0006
561 CONFUSIONAL STATE 93 0.0006
562 SYRINGE ISSUE 10 0.0006
563 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
564 METASTASES TO LIVER 10 0.0006
565 SLEEP DISORDER 40 0.0006
566 MALIGNANT NEOPLASM PROGRESSION 58 0.0006
567 OSTEONECROSIS OF JAW 14 0.0006
568 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
569 PAIN IN JAW 16 0.0006
570 PHARYNGITIS 7 0.0006
571 HAEMATOCHEZIA 31 0.0006
572 FACIAL PAIN 5 0.0006
573 BLOOD BILIRUBIN INCREASED 15 0.0006
574 HYPERTENSION 117 0.0006
575 VOMITING 259 0.0006
576 CHOLELITHIASIS 18 0.0005
577 GASTROOESOPHAGEAL REFLUX DISEASE 44 0.0005
578 HYPERHIDROSIS 70 0.0005
579 HAEMATOMA 14 0.0005
580 BLOOD UREA INCREASED 9 0.0005
581 PANCREATITIS ACUTE 12 0.0005
582 FISTULA 6 0.0005
583 BLOOD POTASSIUM DECREASED 16 0.0005
584 SQUAMOUS CELL CARCINOMA 5 0.0005
585 DYSPNOEA EXERTIONAL 20 0.0005
586 IMPAIRED DRIVING ABILITY 6 0.0005
587 DERMATITIS CONTACT 6 0.0005
588 INTERNATIONAL NORMALISED RATIO INCREASED 15 0.0005
589 RED BLOOD CELL COUNT DECREASED 15 0.0005
590 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
591 EPISTAXIS 39 0.0005
592 JAUNDICE 14 0.0005
593 JOINT INJURY 11 0.0005
594 PALLOR 14 0.0005
595 ABDOMINAL PAIN LOWER 13 0.0005
596 THERAPY PARTIAL RESPONDER 8 0.0005
597 HAEMORRHOIDS 10 0.0005
598 DEHYDRATION 68 0.0005
599 AFFECTIVE DISORDER 4 0.0005
600 ACUTE MYOCARDIAL INFARCTION 15 0.0005
601 PSYCHOTIC DISORDER 15 0.0005
602 BLOOD CREATININE INCREASED 33 0.0005
603 DYSARTHRIA 19 0.0005
604 OVARIAN CYST 5 0.0005
605 SALIVARY HYPERSECRETION 5 0.0005
606 TOOTHACHE 9 0.0005
607 CONTRAINDICATED PRODUCT ADMINISTERED 15 0.0005
608 DYSPHAGIA 47 0.0005
609 MENTAL IMPAIRMENT 12 0.0005
610 RESTLESS LEGS SYNDROME 9 0.0005
611 NEUROPATHY PERIPHERAL 47 0.0005
612 DIALYSIS 7 0.0005
613 MIGRAINE 47 0.0005
614 COMPLETED SUICIDE 41 0.0005
615 NEUTROPHIL COUNT INCREASED 5 0.0005
616 RENAL IMPAIRMENT 41 0.0005
617 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
618 DECREASED APPETITE 113 0.0005
619 ABDOMINAL PAIN 113 0.0005
620 HEPATIC STEATOSIS 9 0.0005
621 MENTAL DISORDER 21 0.0005
622 HYPOKINESIA 7 0.0005
623 DISTURBANCE IN ATTENTION 26 0.0005
624 CYTOMEGALOVIRUS INFECTION 8 0.0005
625 GASTROENTERITIS 7 0.0005
626 HEPATIC CIRRHOSIS 9 0.0005
627 BLOOD SODIUM DECREASED 9 0.0005
628 FOOT FRACTURE 9 0.0005
629 SKIN LESION 13 0.0005
630 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
631 RENAL PAIN 5 0.0005
632 PULMONARY MASS 7 0.0005
633 MEDICATION ERROR 26 0.0005
634 EXPOSURE DURING PREGNANCY 29 0.0005
635 BLOOD PRESSURE DECREASED 31 0.0005
636 BACK PAIN 108 0.0005
637 HIATUS HERNIA 6 0.0005
638 PRODUCTIVE COUGH 22 0.0005
639 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 24 0.0005
640 CLOSTRIDIUM DIFFICILE INFECTION 10 0.0005
641 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
642 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
643 GASTROINTESTINAL PAIN 5 0.0005
644 FIBROMYALGIA 11 0.0005
645 DIABETES MELLITUS INADEQUATE CONTROL 8 0.0005
646 INTESTINAL OBSTRUCTION 17 0.0005
647 PNEUMONIA 146 0.0005
648 COLITIS 17 0.0004
649 RENAL FAILURE ACUTE 19 0.0004
650 QUALITY OF LIFE DECREASED 6 0.0004
651 MALNUTRITION 5 0.0004
652 SKIN INFECTION 5 0.0004
653 INTENTIONAL SELF-INJURY 9 0.0004
654 PYREXIA 154 0.0004
655 ANGER 15 0.0004
656 CHROMATURIA 10 0.0004
657 BLOOD LACTATE DEHYDROGENASE INCREASED 7 0.0004
658 GINGIVAL BLEEDING 6 0.0004
659 ABSCESS 7 0.0004
660 DRUG INEFFECTIVE 578 0.0004
661 TREMOR 72 0.0004
662 PERICARDIAL EFFUSION 10 0.0004
663 ANXIETY 123 0.0004
664 ORAL DISCOMFORT 6 0.0004
665 PRODUCT USE IN UNAPPROVED INDICATION 107 0.0004
666 MUSCULAR WEAKNESS 49 0.0004
667 CARPAL TUNNEL SYNDROME 6 0.0004
668 APPENDICITIS 4 0.0004
669 OSTEONECROSIS 14 0.0004
670 RESPIRATORY TRACT INFECTION 11 0.0004
671 NEUROLEPTIC MALIGNANT SYNDROME 5 0.0004
672 GASTRIC ULCER 8 0.0004
673 LEUKOPENIA 21 0.0004
674 PRODUCT PRESCRIBING ERROR 10 0.0004
675 FALL 139 0.0004
676 IMPAIRED QUALITY OF LIFE 6 0.0004
677 WRIST FRACTURE 5 0.0004
678 LOCALISED INFECTION 10 0.0004
679 C-REACTIVE PROTEIN INCREASED 15 0.0004
680 NEURALGIA 10 0.0004
681 OFF LABEL USE 360 0.0004
682 MENSTRUATION IRREGULAR 11 0.0004
683 URINARY TRACT INFECTION 70 0.0004
684 MELAENA 9 0.0004
685 HAEMATURIA 14 0.0004
686 HYPOTHYROIDISM 13 0.0004
687 INFLAMMATION 21 0.0004
688 NAUSEA 320 0.0004
689 HEART RATE INCREASED 40 0.0004
690 ARRHYTHMIA 19 0.0004
691 RESPIRATORY DISORDER 12 0.0004
692 MUSCULOSKELETAL PAIN 21 0.0004
693 AMNESIA 26 0.0004
694 MUSCULOSKELETAL STIFFNESS 35 0.0004
695 FULL BLOOD COUNT DECREASED 8 0.0004
696 PRODUCT ADMINISTRATION ERROR 8 0.0004
697 LYMPHADENOPATHY 14 0.0004
698 TASTE DISORDER 8 0.0004
699 WOUND 11 0.0004
700 MEMORY IMPAIRMENT 54 0.0004
701 BONE PAIN 23 0.0004
702 HEPATIC CYTOLYSIS 5 0.0004
703 LYMPHOMA 6 0.0004
704 TENDONITIS 6 0.0004
705 OEDEMA PERIPHERAL 47 0.0004
706 SWOLLEN TONGUE 12 0.0004
707 DRUG-INDUCED LIVER INJURY 12 0.0004
708 DEAFNESS 10 0.0004
709 PAIN 234 0.0004
710 BEDRIDDEN 5 0.0004
711 HALLUCINATION, AUDITORY 6 0.0004
712 ULCER 6 0.0004
713 MOOD SWINGS 12 0.0004
714 BLISTER 21 0.0004
715 INTERSTITIAL LUNG DISEASE 18 0.0004
716 MUSCLE TIGHTNESS 6 0.0004
717 ASTHENIA 139 0.0004
718 CEREBRAL INFARCTION 9 0.0004
719 NEUTROPHIL COUNT DECREASED 15 0.0004
720 BIPOLAR DISORDER 4 0.0004
721 CHEST PAIN 68 0.0004
722 CHOLESTASIS 7 0.0004
723 DRUG PRESCRIBING ERROR 7 0.0004
724 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
725 DISEASE PROGRESSION 43 0.0004
726 SPEECH DISORDER 19 0.0004
727 PRESCRIBED OVERDOSE 7 0.0004
728 CARDIAC FAILURE 29 0.0004
729 HYPOAESTHESIA 54 0.0004
730 PROCEDURAL PAIN 10 0.0004
731 DEPRESSED MOOD 19 0.0004
732 ROAD TRAFFIC ACCIDENT 15 0.0004
733 BURNING SENSATION 25 0.0004
734 PRODUCT DOSE OMISSION IN ERROR 10 0.0004
735 SUBDURAL HAEMATOMA 5 0.0003
736 ANGINA PECTORIS 10 0.0003
737 TINNITUS 16 0.0003
738 SKIN DISCOLOURATION 16 0.0003
739 HEAD INJURY 11 0.0003
740 RASH GENERALISED 9 0.0003
741 DEPRESSION 79 0.0003
742 BLOOD PRESSURE INCREASED 53 0.0003
743 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
744 ABDOMINAL DISTENSION 36 0.0003
745 BONE MARROW FAILURE 7 0.0003
746 PRODUCT USE ISSUE 64 0.0003
747 OSTEOPOROSIS 14 0.0003
748 NECK PAIN 19 0.0003
749 DIARRHOEA 219 0.0003
750 DYSPNOEA 192 0.0003
751 EMOTIONAL DISTRESS 41 0.0003
752 SUICIDAL IDEATION 31 0.0003
753 CONDITION AGGRAVATED 102 0.0003
754 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
755 HEPATIC FAILURE 10 0.0003
756 SWELLING 31 0.0003
757 APHASIA 10 0.0003
758 NEOPLASM MALIGNANT 22 0.0003
759 PAIN IN EXTREMITY 97 0.0003
760 PRESYNCOPE 8 0.0003
761 DEVICE FAILURE 5 0.0003
762 ABNORMAL BEHAVIOUR 13 0.0003
763 CYTOPENIA 4 0.0003
764 IRRITABLE BOWEL SYNDROME 7 0.0003
765 FEELING HOT 20 0.0003
766 ABDOMINAL PAIN UPPER 67 0.0003
767 RHINORRHOEA 21 0.0003
768 INFECTION 47 0.0003
769 GAIT DISTURBANCE 62 0.0003
770 MUSCULOSKELETAL CHEST PAIN 5 0.0003
771 EXTRAPYRAMIDAL DISORDER 8 0.0003
772 RENAL DISORDER 15 0.0003
773 HEPATIC FUNCTION ABNORMAL 12 0.0003
774 ACUTE MYELOID LEUKAEMIA 5 0.0003
775 COVID-19 56 0.0003
776 BRAIN FOG 5 0.0003
777 PERIPHERAL SWELLING 49 0.0003
778 DERMATITIS ALLERGIC 4 0.0003
779 ARTHRITIS 25 0.0003
780 HYPOCALCAEMIA 6 0.0003
781 FRACTURE 6 0.0003
782 NEOPLASM PROGRESSION 11 0.0003
783 WEIGHT DECREASED 88 0.0003
784 FEELING JITTERY 6 0.0003
785 SCIATICA 5 0.0003
786 OEDEMA 17 0.0003
787 POST PROCEDURAL COMPLICATION 6 0.0003
788 POLLAKIURIA 13 0.0003
789 INSOMNIA 83 0.0003
790 HEART RATE IRREGULAR 7 0.0003
791 BLOOD POTASSIUM INCREASED 5 0.0003
792 MUSCLE SPASMS 56 0.0003
793 SINUS DISORDER 6 0.0003
794 OROPHARYNGEAL PAIN 28 0.0003
795 BLOOD PRESSURE ABNORMAL 6 0.0003
796 ILLNESS 31 0.0003
797 PLATELET COUNT DECREASED 32 0.0003
798 SKIN DISORDER 10 0.0003
799 DEATH 258 0.0003
800 GAIT INABILITY 10 0.0003
801 CONVULSION 17 0.0003
802 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
803 FEEDING DISORDER 6 0.0003
804 ANGIOEDEMA 13 0.0003
805 AKATHISIA 4 0.0003
806 HOSPITALISATION 45 0.0003
807 DEEP VEIN THROMBOSIS 19 0.0003
808 FEMUR FRACTURE 9 0.0003
809 MUSCULOSKELETAL DISCOMFORT 5 0.0003
810 NASAL CONGESTION 17 0.0003
811 INTENTIONAL DRUG MISUSE 6 0.0003
812 EOSINOPHILIA 5 0.0003
813 BLOOD TEST ABNORMAL 4 0.0003
814 EATING DISORDER 6 0.0003
815 FATIGUE 218 0.0003
816 THERAPY INTERRUPTED 20 0.0003
817 NIGHT SWEATS 9 0.0003
818 HEPATIC ENZYME INCREASED 19 0.0003
819 VISION BLURRED 38 0.0003
820 LIVER FUNCTION TEST ABNORMAL 8 0.0003
821 BONE DISORDER 5 0.0003
822 PANIC ATTACK 10 0.0003
823 CARDIAC FAILURE CONGESTIVE 22 0.0003
824 DYSPHONIA 16 0.0003
825 ERECTILE DYSFUNCTION 7 0.0003
826 ANAPHYLACTIC SHOCK 7 0.0003
827 LABORATORY TEST ABNORMAL 8 0.0003
828 INJURY 19 0.0003
829 BRONCHITIS 20 0.0003
830 SYNCOPE 27 0.0003
831 TOOTH DISORDER 6 0.0003
832 CONJUNCTIVITIS 5 0.0003
833 DRUG INTOLERANCE 26 0.0003
834 COLON CANCER 4 0.0003
835 BACTERIAL INFECTION 5 0.0003
836 SNEEZING 6 0.0003
837 PANCREATITIS 14 0.0003
838 THERAPEUTIC RESPONSE DECREASED 16 0.0003
839 GASTROINTESTINAL HAEMORRHAGE 22 0.0003
840 LOWER LIMB FRACTURE 5 0.0003
841 ARTHRALGIA 107 0.0003
842 EAR PAIN 5 0.0003
843 GASTROINTESTINAL DISORDER 23 0.0003
844 MOOD ALTERED 7 0.0003
845 BASAL CELL CARCINOMA 4 0.0003
846 HEART RATE DECREASED 9 0.0003
847 FLUID RETENTION 13 0.0003
848 BONE DENSITY DECREASED 8 0.0003
849 WEIGHT INCREASED 57 0.0003
850 VAGINAL HAEMORRHAGE 11 0.0003
851 DIABETIC KETOACIDOSIS 6 0.0002
852 NERVOUSNESS 13 0.0002
853 THROMBOSIS 20 0.0002
854 EYE PAIN 14 0.0002
855 INTENTIONAL DOSE OMISSION 7 0.0002
856 ADVERSE DRUG REACTION 22 0.0002
857 IMPAIRED HEALING 8 0.0002
858 HERPES ZOSTER 14 0.0002
859 PRODUCT PREPARATION ERROR 5 0.0002
860 STAPHYLOCOCCAL INFECTION 8 0.0002
861 DIZZINESS 120 0.0002
862 AGEUSIA 6 0.0002
863 FUNGAL INFECTION 8 0.0002
864 HOT FLUSH 18 0.0002
865 UNEVALUABLE EVENT 18 0.0002
866 KNEE ARTHROPLASTY 5 0.0002
867 MOUTH ULCERATION 5 0.0002
868 GASTRIC CANCER 6 0.0002
869 HEPATITIS 6 0.0002
870 HEADACHE 147 0.0002
871 RECTAL HAEMORRHAGE 10 0.0002
872 LACRIMATION INCREASED 7 0.0002
873 DIPLOPIA 6 0.0002
874 DRUG ADMINISTRATION ERROR 7 0.0002
875 NEUTROPENIA 31 0.0002
876 EMOTIONAL DISORDER 7 0.0002
877 INFUSION RELATED REACTION 15 0.0002
878 EAR INFECTION 6 0.0002
879 COUGH 63 0.0002
880 CEREBRAL HAEMORRHAGE 8 0.0002
881 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
882 FEAR 6 0.0002
883 DRY MOUTH 18 0.0002
884 ASTHMA 25 0.0002
885 LIMB INJURY 6 0.0002
886 CYSTITIS 7 0.0002
887 NEPHROLITHIASIS 10 0.0002
888 MOVEMENT DISORDER 7 0.0002
889 PRODUCT DOSE OMISSION ISSUE 64 0.0002
890 AGRANULOCYTOSIS 4 0.0002
891 SWELLING FACE 14 0.0002
892 ILL-DEFINED DISORDER 13 0.0002
893 DISCOMFORT 13 0.0002
894 HYPERSENSITIVITY 39 0.0002
895 HYPERSOMNIA 6 0.0002
896 HYPOACUSIS 9 0.0002
897 ABDOMINAL DISCOMFORT 35 0.0002
898 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
899 PANCREATIC CARCINOMA 6 0.0002
900 CHOKING 4 0.0002
901 DYSPEPSIA 20 0.0002
902 HAEMORRHAGE 21 0.0002
903 ANAPHYLACTIC REACTION 11 0.0002
904 CORONARY ARTERY DISEASE 6 0.0002
905 VERTIGO 12 0.0002
906 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
907 PRURITUS 75 0.0002
908 DRUG RESISTANCE 5 0.0002
909 LIMB DISCOMFORT 6 0.0002
910 DRUG EFFECT INCOMPLETE 7 0.0002
911 PARAESTHESIA 30 0.0002
912 MULTIPLE SCLEROSIS RELAPSE 13 0.0002
913 MYALGIA 32 0.0002
914 SURGERY 11 0.0002
915 DRY SKIN 25 0.0002
916 PAIN OF SKIN 5 0.0002
917 RHEUMATOID ARTHRITIS 21 0.0002
918 DIABETES MELLITUS 14 0.0002
919 CEREBROVASCULAR ACCIDENT 31 0.0002
920 TREATMENT NONCOMPLIANCE 10 0.0002
921 DEVICE DELIVERY SYSTEM ISSUE 5 0.0002
922 RASH 79 0.0002
923 MOBILITY DECREASED 13 0.0002
924 VIRAL INFECTION 6 0.0002
925 FLATULENCE 10 0.0002
926 SINUSITIS 18 0.0002
927 BLOOD GLUCOSE INCREASED 33 0.0002
928 ABORTION SPONTANEOUS 7 0.0002
929 NASOPHARYNGITIS 32 0.0002
930 PSORIATIC ARTHROPATHY 7 0.0002
931 NEEDLE ISSUE 5 0.0002
932 WHEEZING 10 0.0002
933 FEELING ABNORMAL 40 0.0002
934 MYOCARDIAL INFARCTION 29 0.0002
935 CONTUSION 16 0.0002
936 DEPENDENCE 9 0.0002
937 EPILEPSY 5 0.0002
938 ALOPECIA 32 0.0002
939 BALANCE DISORDER 14 0.0002
940 ARTHROPATHY 9 0.0002
941 MALAISE 70 0.0002
942 LIVER DISORDER 7 0.0002
943 CARDIOVASCULAR DISORDER 4 0.0002
944 FLUSHING 16 0.0002
945 HIP FRACTURE 5 0.0002
946 LOWER RESPIRATORY TRACT INFECTION 7 0.0002
947 PALPITATIONS 18 0.0002
948 INFLUENZA 17 0.0002
949 TRANSIENT ISCHAEMIC ATTACK 5 0.0001
950 DISEASE RECURRENCE 7 0.0001
951 MULTIPLE SCLEROSIS 7 0.0001
952 CARDIAC DISORDER 13 0.0001
953 CRYING 5 0.0001
954 CHEST DISCOMFORT 14 0.0001
955 THERAPY CESSATION 7 0.0001
956 CATARACT 8 0.0001
957 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
958 JOINT SWELLING 16 0.0001
959 SKIN IRRITATION 6 0.0001
960 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
961 RASH ERYTHEMATOUS 6 0.0001
962 LUNG DISORDER 6 0.0001
963 VISUAL IMPAIRMENT 15 0.0001
964 TREATMENT FAILURE 10 0.0001
965 ADVERSE EVENT 11 0.0001
966 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 24 0.0001
967 NO ADVERSE EVENT 21 0.0001
968 DEVICE DISLOCATION 5 0.0001
969 COLITIS ULCERATIVE 5 0.0001
970 DEVICE ISSUE 10 0.0001
971 THROAT IRRITATION 5 0.0001
972 RASH PRURITIC 6 0.0001
973 UNDERDOSE 8 0.0001
974 BLOOD CHOLESTEROL INCREASED 5 0.0001
975 OCULAR HYPERAEMIA 5 0.0001
976 BLOOD GLUCOSE DECREASED 5 0.0001
977 DERMATITIS ATOPIC 5 0.0001
978 DYSGEUSIA 7 0.0001
979 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
980 SKIN EXFOLIATION 7 0.0001
981 INCORRECT DOSE ADMINISTERED 18 0.0001
982 INJECTION SITE SWELLING 6 0.0001
983 INFLUENZA LIKE ILLNESS 6 0.0001
984 URTICARIA 12 0.0001
985 SKIN BURNING SENSATION 5 0.0001
986 PSORIASIS 9 0.0001
987 ERYTHEMA 14 0.0001
988 DRUG DOSE OMISSION 9 0.0001
989 BREAST CANCER 5 0.0001
990 PRODUCT QUALITY ISSUE 7 0.0001
991 INJECTION SITE PAIN 12 0.0000